September 10, 2011 - Volume 25 - Issue 14 - Contributor Index

Alphabetical Search
I
Q
Y
Z
Author:
Abadjian, Linda

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Author:
An, Ping

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

Author:
Badiee, Jayraan

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
Bendavid, Eran
Author:
Berkhout, Ben

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Author:
Berzon, Richard
Author:
Billaud, Eric

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Author:
Boulle, Andrew

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Calosing, Cyrus
Author:
Chao, Chun
Author:
Chen, Shuguang

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Christ, Frauke

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Author:
Clifford, David

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

Author:
Collier, Ann C.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
Debyser, Zeger

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Author:
DeJesus, Edwin

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

Author:
Domingo, Pere

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

Author:
Egger, Matthias

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
Emery, Sean

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Author:
Ferris, Robert
Author:
Fidler, Sarah
Author:
Filler, Scott

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Fortin, Claude
Author:
Fox, Julie
Author:
Fox, Matthew P.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Fujiwara, Tamio

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
Ghannoum, Marc
Author:
Gijsbers, Rik

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Author:
Grant, Igor

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
Gsponer, Thomas

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Hawkins, Trevor

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Author:
Hu, Zonghui

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Author:
Keiser, Olivia

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Kesmir, Can

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Author:
Khabo, Paul

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Author:
Lalezari, Jay

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

Author:
Letendre, Scott

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

Author:
Long, Elisa F.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Author:
Maja, Patrick

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Author:
Manzini, Prince

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Author:
Maskew, Mhairi

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Matchaba, Gugu

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Author:
Maxwell, Nicola

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
McCurdy, Lewis

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
McIlroy, Dorian

Despite an impaired response to IL-7, T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI

Pacheco, Yovana; Solé, Véronique; Billaud, Eric; More

AIDS . 25(14):1701-1710, September 10, 2011.

Author:
Metcalf, Julie

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Author:
Miedema, Frank

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Author:
Min, Sherene

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.

Author:
Mlisana, Koleka

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Llibre, Josep M.; Arribas, José R.; Domingo, Pere; More

AIDS . 25(14):1683-1690, September 10, 2011.

Author:
Morgello, Susan

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Ellis, Ronald J.; Badiee, Jayraan; Vaida, Florin; More

AIDS . 25(14):1747-1751, September 10, 2011.

Author:
Navis, Marjon

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic

Schellens, Ingrid M.M.; Navis, Marjon; van Deutekom, Hanneke W.M.; More

AIDS . 25(14):1691-1700, September 10, 2011.

Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

Madlala, Paradise; Gijsbers, Rik; Christ, Frauke; More

AIDS . 25(14):1711-1719, September 10, 2011.

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

Keiser, Olivia; Chi, Benjamin H.; Gsponer, Thomas; More

AIDS . 25(14):1761-1769, September 10, 2011.

Author:
Orsega, Susan

Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa

Matthews, Gail V.; Manzini, Prince; Hu, Zonghui; More

AIDS . 25(14):1727-1735, September 10, 2011.

Author:
Over, Mead
1 2 Next